Congress trading in DVA
2 members of Congress have disclosed trading DVA — 1 purchase and 1 sale worth an estimated $16,000. Most recent disclosure: Sep 25, 2025.
About DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DVA Key Statistics
DVA in plain English
- P/E ratio (20.9) — how many dollars you pay for each $1 of DVA's yearly profit. That's a fairly normal range.
- ROE (80.98%) — how efficiently the company turns shareholders' money into profit. Above ~20% is considered strong.
- Profit margin (5.65%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend — DVA doesn't pay a meaningful dividend; the return here comes from the share price, not cash payouts.
Compare DVA with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.